BioLife Solutions Debt to Equity Ratio 2010-2025 | BLFS
Current and historical debt to equity ratio values for BioLife Solutions (BLFS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. BioLife Solutions debt/equity for the three months ending March 31, 2025 was 0.01.
| BioLife Solutions Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.04B | $0.35B | 0.12 |
| 2024-12-31 | $0.05B | $0.35B | 0.15 |
| 2024-09-30 | $0.06B | $0.33B | 0.17 |
| 2024-06-30 | $0.05B | $0.32B | 0.17 |
| 2024-03-31 | $0.07B | $0.33B | 0.21 |
| 2023-12-31 | $0.08B | $0.34B | 0.22 |
| 2023-09-30 | $0.08B | $0.33B | 0.24 |
| 2023-06-30 | $0.08B | $0.35B | 0.23 |
| 2023-03-31 | $0.09B | $0.36B | 0.25 |
| 2022-12-31 | $0.09B | $0.36B | 0.24 |
| 2022-09-30 | $0.08B | $0.41B | 0.20 |
| 2022-06-30 | $0.06B | $0.41B | 0.14 |
| 2022-03-31 | $0.07B | $0.48B | 0.14 |
| 2021-12-31 | $0.08B | $0.48B | 0.16 |
| 2021-09-30 | $0.07B | $0.49B | 0.14 |
| 2021-06-30 | $0.07B | $0.45B | 0.15 |
| 2021-03-31 | $0.03B | $0.21B | 0.15 |
| 2020-12-31 | $0.03B | $0.21B | 0.14 |
| 2020-09-30 | $0.01B | $0.19B | 0.05 |
| 2020-06-30 | $0.01B | $0.11B | 0.08 |
| 2020-03-31 | $0.03B | $0.07B | 0.40 |
| 2019-12-31 | $0.05B | $0.04B | 1.14 |
| 2019-09-30 | $0.01B | $0.08B | 0.09 |
| 2019-06-30 | $0.01B | $0.05B | 0.12 |
| 2019-03-31 | $0.00B | $0.04B | 0.08 |
| 2018-12-31 | $0.03B | $0.02B | 2.11 |
| 2018-09-30 | $0.00B | $0.04B | 0.06 |
| 2018-06-30 | $0.00B | $0.02B | 0.11 |
| 2018-03-31 | $0.00B | $0.01B | 0.17 |
| 2017-12-31 | $0.00B | $0.01B | 0.20 |
| 2017-09-30 | $0.00B | $0.01B | 0.23 |
| 2017-06-30 | $0.00B | $0.01B | 0.24 |
| 2017-03-31 | $0.01B | $0.00B | 2.07 |
| 2016-12-31 | $0.01B | $0.00B | 1.50 |
| 2016-09-30 | $0.00B | $0.01B | 0.63 |
| 2016-06-30 | $0.00B | $0.01B | 0.40 |
| 2016-03-31 | $0.00B | $0.01B | 0.26 |
| 2015-12-31 | $0.00B | $0.01B | 0.26 |
| 2015-09-30 | $0.00B | $0.01B | 0.23 |
| 2015-06-30 | $0.00B | $0.01B | 0.17 |
| 2015-03-31 | $0.00B | $0.01B | 0.18 |
| 2014-12-31 | $0.00B | $0.01B | 0.15 |
| 2014-09-30 | $0.00B | $0.01B | 0.13 |
| 2014-06-30 | $0.00B | $0.01B | 0.11 |
| 2014-03-31 | $0.00B | $0.01B | 0.14 |
| 2013-12-31 | $0.02B | $-0.01B | -1.25 |
| 2013-09-30 | $0.02B | $-0.01B | -1.25 |
| 2013-06-30 | $0.02B | $-0.01B | -1.27 |
| 2013-03-31 | $0.02B | $-0.01B | -1.28 |
| 2012-12-31 | $0.02B | $-0.01B | -1.25 |
| 2012-09-30 | $0.02B | $-0.01B | -1.28 |
| 2012-06-30 | $0.02B | $-0.01B | -1.26 |
| 2012-03-31 | $0.01B | $-0.01B | -1.16 |
| 2011-12-31 | $0.01B | $-0.01B | -1.15 |
| 2011-09-30 | $0.01B | $-0.01B | -1.15 |
| 2011-06-30 | $0.01B | $-0.01B | -1.14 |
| 2011-03-31 | $0.01B | $-0.01B | -1.14 |
| 2010-12-31 | $0.01B | $-0.01B | -1.14 |
| 2010-09-30 | $0.01B | $-0.01B | -1.14 |
| 2010-06-30 | $0.01B | $-0.01B | -1.16 |
| 2010-03-31 | $0.01B | $-0.01B | -1.16 |
| 2009-12-31 | $0.01B | $-0.01B | -1.17 |
| 2009-09-30 | $0.01B | $-0.01B | -1.18 |
| 2009-06-30 | $0.01B | $-0.01B | -1.17 |
| 2009-03-31 | $0.01B | $-0.01B | -1.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.006B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.206B | 27.56 |
| Boston Scientific (BSX) | United States | $152.664B | 38.22 |
| Stryker (SYK) | United States | $149.191B | 31.19 |
| EssilorLuxottica (ESLOY) | France | $131.913B | 0.00 |
| Medtronic (MDT) | Ireland | $115.147B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.094B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.531B | 24.85 |
| ResMed (RMD) | United States | $37.280B | 28.00 |
| GE HealthCare Technologies (GEHC) | United States | $34.547B | 16.40 |
| Agilent Technologies (A) | United States | $32.221B | 21.01 |
| Terumo (TRUMY) | Japan | $24.355B | 31.64 |
| Koninklijke Philips (PHG) | Netherlands | $23.476B | 16.47 |
| Insulet (PODD) | United States | $20.287B | 79.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.641B | 11.97 |
| Baxter (BAX) | United States | $14.559B | 10.87 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.951B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.729B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.148B | 12.99 |
| Perrigo (PRGO) | Ireland | $3.724B | 9.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.715B | 16.59 |
| Haemonetics (HAE) | United States | $3.575B | 16.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.342B | 27.77 |
| ICU Medical (ICUI) | United States | $3.072B | 22.66 |
| LeMaitre Vascular (LMAT) | United States | $1.867B | 41.72 |
| QuidelOrtho (QDEL) | United States | $1.864B | 12.82 |
| AtriCure (ATRC) | United States | $1.504B | 0.00 |
| Acuren (TIC) | United States | $1.431B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.238B | 15.82 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Green Thumb Industries (GTBIF) | United States | $1.212B | 27.26 |
| Neogen (NEOG) | United States | $1.068B | 13.67 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.788B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Tilray Brands (TLRY) | Canada | $0.607B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.571B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Surmodics (SRDX) | United States | $0.446B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.331B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.321B | 11.82 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.300B | 0.00 |
| Quanterix (QTRX) | United States | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.30 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.75 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.202B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.152B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.16 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.87 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.76 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 49.29 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |